American Century Companies’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
AC
PA
VCM
NAMI
American Century Companies's TVTX Position: Q1 2026 in Review
American Century Companies opened a new position in Travere Therapeutics (TVTX) in Q1 2026: 23,814 shares worth $708K. The stake represents ﹤0.01% of the portfolio and ranks #2430 among its holdings. This is a return to the name: American Century Companies previously reported a position in TVTX as recently as Q2 2018.
American Century Companies first reported a position in TVTX in Q3 2016 and has held it in 9 quarters since. The position peaked at $7.12M in Q3 2017. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.
- American Century Companies held 23,814 shares of Travere Therapeutics worth $708K as of Q1 2026.
- Travere Therapeutics was a new American Century Companies position in Q1 2026.
- Travere Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2430 holding.
- American Century Companies first reported a position in Travere Therapeutics in Q3 2016 and has held it in 9 quarters since.
- American Century Companies's Travere Therapeutics position peaked at $7.12M in Q3 2017.
- 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.